Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Videos | Chronic Total Occlusion (CTO) | September 17, 2018

A discussion with Khaldoon Alaswad, M.D., director, cardiac catheterization lab, Henry Ford Hospital, on treating...

4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018

September 17, 2018 — 4C Medical Technologies Inc. announced that its AltaValve...

Videos | Stents | September 11, 2018

This is an animation showing how the dedicated bifurcation stent developed by Advanced Bifurcation Systems (ABS) is...

Videos | Hemodynamic Support Devices | September 22, 2018

There was a 77 percent increase in survival in cardiogenic shock patients treated using a new protocol in the...

Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics. #TCT #TCT18 #TCT2018
Feature | TCT | September 14, 2018 | Dave Fornell, Editor

The volume of information attendees receive at the annual...

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian

Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and...

Gore Acquires Pipeline Medical Technologies Inc.
News | Heart Valve Technology | September 06, 2018

September 6, 2018 – W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical...

Figure 1: Segmentation performed on the left atrium, left ventricle and mitral bioprosthesis. Landmarks are placed on the site of optimal transseptal access into the left atrium and the mitral PVL.

Figure 1: Segmentation performed on the left atrium, left ventricle and mitral bioprosthesis. Landmarks are placed on the site of optimal transseptal access into the left atrium and the mitral PVL.

Sponsored Content | Case Study | Ultrasound Transesophageal echo (TEE) | September 05, 2018 | Cyril Danielkutty B.E., Dillon Weiss, B.S., Chad A Kliger, M.D., M.S.

Transcatheter interventions have become a mainstay in cardiac care as treatments for structural and congenital heart...

The Fysicon QMAPP hemodynamic monitoring system is the newest system to gain FDA clearance. It is about the size of a ream of paper.

The Fysicon QMAPP hemodynamic monitoring system is the newest system to gain FDA clearance. It is about the size of a ream of paper.

Feature | Hemodynamic Monitoring Systems | September 05, 2018 | Dave Fornell, Editor

Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab,...

SCAI and the European Society of Cardiology recently added iFR to their guidelines.

An illustration of Philip’s iFR technology, showing the iFR pressure readings and a fusion angio image indicating pressure drops in the vessel during wire pull back. SCAI and the European Society of Cardiology recently added iFR to their guidelines.

Feature | FFR Technologies | September 05, 2018 | Dave Fornell, Editor

The use of invasive, pressure wire-based fractional flow reserve (FFR) in the cath lab is now considered the gold...

The Zoll LifeVest wearable defibrillator system was evaluated in the late-breaking VEST Trial presented at ACC 2018 earlier this year. A review article on the results was the No. 1 most viewed article in July and August.

The Zoll LifeVest wearable defibrillator system was evaluated in the late-breaking VEST Trial presented at ACC 2018 earlier this year. A review article on the results was the No. 1 most viewed article in July and August. 

Feature | September 04, 2018 | Dave Fornell, Editor

September 4, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...

Videos | Hemodynamic Support Devices | August 31, 2018

Behnam Tehrani, M.D., FSCAI, director of the cardiac cath lab, INOVA Heart and Vascular Institute, Fairfax, Va.,...

Overlay Init